Higher Concentrations of Parathyroid Hormone (PTH) are Associated with Reduced Gait Velocity in Adults : A Systematic Review
Copyright © 2021 Elsevier B.V. All rights reserved..
INTRODUCTION/OBJECTIVES: High serum concentrations of parathyroid hormone (PTH) have been associated with osteoporosis, sarcopenia and osteosarcopenia. Gait velocity is a predictor of adverse outcomes. This systematic review aimed to assess the observational evidence studying the association of PTH concentrations with gait velocity in adults.
METHODS: We searched PubMed, Embase (Ovid interface) and Cochrane (CENTRAL) for published studies evaluating circulating PTH in human adults aged >20 years, without date or language restriction. We excluded studies with patients on dialysis and if PTH was measured following any intervention having a potential effect on its concentrations. Primary outcome was gait velocity, defined as the time needed to walk a predetermined distance or distance walked during a fixed period at usual pace or fast pace. Two independent researchers conducted data extraction and evaluated the risk of bias. A third reviewer resolved disagreements. Risk of bias assessment was done using the National Heart, Lung and Blood Institute quality assessment tool.
RESULTS: A total of 681 articles were retrieved from the systematic search. Following full-text review and risk of bias assessment, 8 studies were included for final analysis. Of the included studies, three demonstrated a significant inverse association between high PTH concentrations and gait velocity, one study showed an indirect association, and two studies showed a non-significant association of increasing PTH levels with declining gait speed. Two studies showed no relation. In addition, three of the studies also highlighted a negative correlation between PTH levels and muscle strength.
CONCLUSION: Our review of published studies suggests that higher concentrations of PTH are associated with reduced gait velocity in adults. This relationship deserves further exploration with RCTs designed to assess the effects of correcting abnormal circulating PTH levels on physical performance in adults.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:99 |
|---|---|
| Enthalten in: |
Archives of gerontology and geriatrics - 99(2022) vom: 24. März, Seite 104579 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Murthy, Lavanya Srinivasa [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Falls |
|---|
| Anmerkungen: |
Date Completed 11.03.2022 Date Revised 11.03.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.archger.2021.104579 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM333933591 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM333933591 | ||
| 003 | DE-627 | ||
| 005 | 20231225222653.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.archger.2021.104579 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1113.xml |
| 035 | |a (DE-627)NLM333933591 | ||
| 035 | |a (NLM)34856523 | ||
| 035 | |a (PII)S0167-4943(21)00242-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Murthy, Lavanya Srinivasa |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Higher Concentrations of Parathyroid Hormone (PTH) are Associated with Reduced Gait Velocity in Adults |b A Systematic Review |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.03.2022 | ||
| 500 | |a Date Revised 11.03.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 Elsevier B.V. All rights reserved. | ||
| 520 | |a INTRODUCTION/OBJECTIVES: High serum concentrations of parathyroid hormone (PTH) have been associated with osteoporosis, sarcopenia and osteosarcopenia. Gait velocity is a predictor of adverse outcomes. This systematic review aimed to assess the observational evidence studying the association of PTH concentrations with gait velocity in adults | ||
| 520 | |a METHODS: We searched PubMed, Embase (Ovid interface) and Cochrane (CENTRAL) for published studies evaluating circulating PTH in human adults aged >20 years, without date or language restriction. We excluded studies with patients on dialysis and if PTH was measured following any intervention having a potential effect on its concentrations. Primary outcome was gait velocity, defined as the time needed to walk a predetermined distance or distance walked during a fixed period at usual pace or fast pace. Two independent researchers conducted data extraction and evaluated the risk of bias. A third reviewer resolved disagreements. Risk of bias assessment was done using the National Heart, Lung and Blood Institute quality assessment tool | ||
| 520 | |a RESULTS: A total of 681 articles were retrieved from the systematic search. Following full-text review and risk of bias assessment, 8 studies were included for final analysis. Of the included studies, three demonstrated a significant inverse association between high PTH concentrations and gait velocity, one study showed an indirect association, and two studies showed a non-significant association of increasing PTH levels with declining gait speed. Two studies showed no relation. In addition, three of the studies also highlighted a negative correlation between PTH levels and muscle strength | ||
| 520 | |a CONCLUSION: Our review of published studies suggests that higher concentrations of PTH are associated with reduced gait velocity in adults. This relationship deserves further exploration with RCTs designed to assess the effects of correcting abnormal circulating PTH levels on physical performance in adults | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Systematic Review | |
| 650 | 4 | |a Parathyroid hormone | |
| 650 | 4 | |a falls | |
| 650 | 4 | |a fractures | |
| 650 | 4 | |a gait velocity | |
| 650 | 4 | |a osteosarcopenia | |
| 650 | 7 | |a Parathyroid Hormone |2 NLM | |
| 700 | 1 | |a de França, Natasha A Grande |e verfasserin |4 aut | |
| 700 | 1 | |a Duval, Guillaume T |e verfasserin |4 aut | |
| 700 | 1 | |a Vogrin, Sara |e verfasserin |4 aut | |
| 700 | 1 | |a Annweiler, Cedric |e verfasserin |4 aut | |
| 700 | 1 | |a Duque, Gustavo |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Archives of gerontology and geriatrics |d 1990 |g 99(2022) vom: 24. März, Seite 104579 |w (DE-627)NLM023899212 |x 1872-6976 |7 nnns |
| 773 | 1 | 8 | |g volume:99 |g year:2022 |g day:24 |g month:03 |g pages:104579 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.archger.2021.104579 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 99 |j 2022 |b 24 |c 03 |h 104579 | ||